BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kardani K, Bolhassani A, Namvar A. An overview of in silico vaccine design against different pathogens and cancer. Expert Rev Vaccines 2020;19:699-726. [PMID: 32648830 DOI: 10.1080/14760584.2020.1794832] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Couto J, Seixas G, Stutzer C, Olivier NA, Maritz-Olivier C, Antunes S, Domingos A. Probing the Rhipicephalusbursa Sialomes in Potential Anti-Tick Vaccine Candidates: A Reverse Vaccinology Approach. Biomedicines 2021;9:363. [PMID: 33807386 DOI: 10.3390/biomedicines9040363] [Reference Citation Analysis]
2 Kumar S, Shuaib M, Prajapati KS, Singh AK, Choudhary P, Singh S, Gupta S. A candidate triple-negative breast cancer vaccine design by targeting clinically relevant cell surface markers: an integrated immuno and bio-informatics approach. 3 Biotech 2022;12. [DOI: 10.1007/s13205-022-03140-3] [Reference Citation Analysis]
3 Soltan MA, Eldeen MA, Elbassiouny N, Mohamed I, El-Damasy DA, Fayad E, Abu Ali OA, Raafat N, Eid RA, Al-Karmalawy AA. Proteome Based Approach Defines Candidates for Designing a Multitope Vaccine against the Nipah Virus. Int J Mol Sci 2021;22:9330. [PMID: 34502239 DOI: 10.3390/ijms22179330] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Akbari E, Kardani K, Namvar A, Ajdary S, Ardakani EM, Khalaj V, Bolhassani A. In silico design and in vitro expression of novel multiepitope DNA constructs based on HIV-1 proteins and Hsp70 T-cell epitopes. Biotechnol Lett 2021;43:1513-50. [PMID: 33987776 DOI: 10.1007/s10529-021-03143-9] [Reference Citation Analysis]
5 Viana Invenção MDC, Melo ARDS, de Macêdo LS, da Costa Neves TSP, de Melo CML, Cordeiro MN, de Aragão Batista MV, de Freitas AC. Development of synthetic antigen vaccines for COVID-19. Hum Vaccin Immunother 2021;:1-16. [PMID: 34613880 DOI: 10.1080/21645515.2021.1974288] [Reference Citation Analysis]
6 Kardani K, Sadat SM, Kardani M, Bolhassani A. The next generation of HCV vaccines: a focus on novel adjuvant development. Expert Rev Vaccines 2021;20:839-55. [PMID: 34114513 DOI: 10.1080/14760584.2021.1941895] [Reference Citation Analysis]
7 Shabani SH, Kardani K, Milani A, Bolhassani A. In Silico and in Vivo Analysis of HIV-1 Rev Regulatory Protein for Evaluation of a Multiepitope-based Vaccine Candidate. Immunol Invest 2021;:1-28. [PMID: 33416004 DOI: 10.1080/08820139.2020.1867163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ullah N, Anwer F, Ishaq Z, Siddique A, Shah MA, Rahman M, Rahman A, Mao X, Jiang T, Lee BL, Bae T, Ali A. In silico designed Staphylococcus aureus B-cell multi-epitope vaccine did not elicit antibodies against target antigens suggesting multi-domain approach. J Immunol Methods 2022;:113264. [PMID: 35341759 DOI: 10.1016/j.jim.2022.113264] [Reference Citation Analysis]
9 Sharma SK, Srivastava S, Kumar A, Srivastava V. Anticipation of Antigenic Sites for the Goal of Vaccine Designing Against Nipah Virus: An Immunoinformatics Inquisitive Quest. Int J Pept Res Ther 2021;:1-13. [PMID: 33994898 DOI: 10.1007/s10989-021-10219-7] [Reference Citation Analysis]
10 Asghari A, Majidiani H, Nemati T, Fatollahzadeh M, Shams M, Naserifar R, Kordi B. Toxoplasma gondii Tyrosine-Rich Oocyst Wall Protein: A Closer Look through an In Silico Prism. Biomed Res Int 2021;2021:1315618. [PMID: 34692826 DOI: 10.1155/2021/1315618] [Reference Citation Analysis]
11 Soltan MA, Eldeen MA, Elbassiouny N, Kamel HL, Abdelraheem KM, El-Gayyed HA, Gouda AM, Sheha MF, Fayad E, Ali OAA, Ghany KAE, El-Damasy DA, Darwish KM, Elhady SS, Sileem AE. In Silico Designing of a Multitope Vaccine against Rhizopus microsporus with Potential Activity against Other Mucormycosis Causing Fungi. Cells 2021;10:3014. [PMID: 34831237 DOI: 10.3390/cells10113014] [Reference Citation Analysis]
12 Chakraborty C, Sharma AR, Bhattacharya M, Sharma G, Lee SS. Immunoinformatics Approach for the Identification and Characterization of T Cell and B Cell Epitopes towards the Peptide-Based Vaccine against SARS-CoV-2. Arch Med Res 2021;52:362-70. [PMID: 33546870 DOI: 10.1016/j.arcmed.2021.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Patni K, Agarwal P, Kumar A, Meena LS. Computational evaluation of anticipated PE_PGRS39 protein involvement in host-pathogen interplay and its integration into vaccine development. 3 Biotech 2021;11:204. [PMID: 33824847 DOI: 10.1007/s13205-021-02746-3] [Reference Citation Analysis]